TURNSTONE BIOLOGICS CORP (TSBX) Stock Balance Sheet
NASDAQ:TSBX - Nasdaq - US90042W1009 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 21.85M | 28.93M | 17.80M | 34.73M | 123.38M | |||
| Marketable Securities | N/A | 0.00 | 76.98M | 47.33M | 37.64M | |||
| Receivables | N/A | 0.00 | 194.00K | 8.73M | 6.71M | |||
| Other Current Assets | 5.01M | 5.29M | 7.58M | 7.21M | 9.61M | |||
| Total Current Assets | 26.86M | 34.22M | 102.55M | 98.00M | 177.34M | |||
| Non-Current Assets | ||||||||
| PPE Net | 488.00K | 5.11M | 9.12M | 14.36M | 9.37M | |||
| Other Non-Current Assets | 267.00K | 811.00K | 1.14M | 2.58M | 536.00K | |||
| Total Non-Current Assets | 755.00K | 5.92M | 10.26M | 16.94M | 9.90M | |||
| TOTAL ASSETS | 27.61M | 40.14M | 112.81M | 114.94M | 187.24M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 4.47M | 6.49M | 11.93M | 16.23M | 20.83M | |||
| Accounts Payable | 1.70M | 870.00K | 36.00K | 3.44M | 28.00K | |||
| Other Current Liabilities | 1.09M | 837.00K | 0.00 | 15.16M | 34.12M | |||
| Total Current Liabilities | 7.26M | 8.20M | 11.97M | 34.83M | 54.98M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 369.00K | 473.00K | 2.18M | 9.63M | 42.37M | |||
| Total Non-Current Liabilities | 369.00K | 473.00K | 2.18M | 9.63M | 42.37M | |||
| TOTAL LIABILITIES | 7.63M | 8.67M | 14.15M | 44.46M | 97.34M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -259.40M | -247.59M | -176.76M | -121.56M | -90.72M | |||
| Additional Paid In Capital | 279.57M | 279.24M | 275.52M | 20.50M | 9.12M | |||
| Common Shares | 23.00K | 23.00K | 23.00K | 171.95M | 171.76M | |||
| Other Shareholders' Equity | -202.00K | -202.00K | -119.00K | -413.00K | -245.00K | |||
| Shares Outstanding | 23.14M | 23.14M | 147.89M | 22.19M | 22.19M | |||
| Tangible Book Value per Share | 0.86 | 1.36 | 0.67 | -4.57 | -3.69 | |||
| Total Shareholders' Equity | 19.99M | 31.47M | 98.67M | 70.48M | 89.90M | |||
| TOTAL LIABILITIES AND EQUITY | 27.61M | 40.14M | 112.81M | 114.94M | 187.24M | |||
| Statistics | ||||||||
| Current Ratio | 3.70 | 4.17 | 8.57 | 2.81 | 3.23 | |||
| Return On Assets (ROA) | -228.20% | -176.48% | -48.96% | -26.99% | 1.86% | |||
| Return On Equity (ROE) | -315.29% | -225.12% | -55.99% | -44.02% | 3.87% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | 19.71% | |||
All data in USD , ROIC based on taxRate of 0.21